Literature DB >> 13459220

Clinical experience with sulfonylurea compounds in diabetes.

A MARBLE, R CAMERINI-DAVALOS.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/therapeutic use

Mesh:

Substances:

Year:  1957        PMID: 13459220

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Experience with glipasol (R. P. 2259)-an antidiabetic sulfonamide drug.

Authors:  T W DAVIS; R B KERR; A BOGOCH
Journal:  Can Med Assoc J       Date:  1959-07-15       Impact factor: 8.262

2.  Oral hypoglycaemic drugs.

Authors:  J D SLATER
Journal:  Postgrad Med J       Date:  1959-05       Impact factor: 2.401

3.  The clinical response and the amount of insulin extractable from the pancreas in diabetic patients treated with oral hypoglycaemic drugs: a report on five cases.

Authors:  A BOGOCH; T W DAVIS; E JOW; G A WRENSHALL
Journal:  Can Med Assoc J       Date:  1959-09-01       Impact factor: 8.262

Review 4.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

5.  The diabetic day-care unit. I. Development of an index to evaluate diabetes control.

Authors:  L Noviks; B King; W B Spaulding
Journal:  Can Med Assoc J       Date:  1976-05-08       Impact factor: 8.262

6.  Retrospective glycemic status of diabetic patients: glycosylation of blood proteins in diabetes and chronic renal failure.

Authors:  K Kumari; V Bansal; C G Agarwal; A K Rastogi; M K Sahib
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

7.  Serum cholesterol binding reserve percentage in diabetes mellitus.

Authors:  A Ghatak; K B Bhatia; A Chandra; N K Kapoor
Journal:  Acta Diabetol Lat       Date:  1985 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.